Perspective Therapeutics Overview
Perspective Therapeutics Target Price
Analysts' 12-month price predictions for CATX.
Get informed when a big investor buys or sells
+ FollowShare Price
$3.05
Average Target Price
$12.00
293.4% upside
293.4% upside1 analysts in the last 4 months
High: $12 | Low: $12
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-17 | Truist FinancialGreg Renza | $12 | 293.4% upside |  |
| 2026-02-19 | Piper SandlerBiren Amin | $16 | 424.6% upside | |
| 2026-01-30 | H.C. Wainwright | $12 | 293.4% upside | |
| 2025-11-21 | UBSDavid Lai | $7 | 129.5% upside | |
| 2025-10-10 | BTIGJeet Mukherjee | $14 | 359% upside | |
| 2024-10-24 | UBSDavid Dai | $20 | 555.7% upside | |
| 2024-10-14 | OppenheimerJeff Jones | $22 | 621.3% upside | |
| 2024-09-25 | Truist FinancialNicole Germino | $21 | 588.5% upside | |
| 2024-07-25 | Bank of America SecuritiesAlec Stranahan | $24 | 686.9% upside | |
| 2024-06-18 | OppenheimerJeff Jones | $19 | 523% upside | |
| 2024-06-14 | RBC CapitalGregory Renza | $3 |  1.6% downside | |
| 2024-05-15 | OppenheimerJeff Jones | $2 | 34.4% downside | |